RECORDATI (RER1 BE) stock market data APIs
€49.4643
1.08(2.2%)
as of November 7, 2025
Try our APIs with
free plan!
RECORDATI Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for RER1.BE.
Prev. Close
49.4643
Open
50.5482
High
50.5482
Low
49.1416
52 wk Range
43.7849-60.1424
Market Cap
11 024 M
Dividends (Yield)
0.0251
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get RECORDATI data using free add-ons & libraries
Get RECORDATI Fundamental Data
RECORDATI Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: 0.77
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
RECORDATI News
New
European Market Gems 3 Stocks Estimated To Be Trading Below Intrinsic Value
As European markets experience a notable upswing, with the STOXX Europe 600 Index and major stock indexes like Germany’s DAX and the UK’s FTSE 100 showing strong gains, investors are increasingly ...
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
Recordati NEWS RELEASE Milan, 23 October 2025 – Recordati, a global pharmaceutical company, announces today that Mike McClellan will join as its new Chief Financial Officer (CFO) as of January 1, ...
Recordati Launches 12th Edition of Arrigo Recordati Prize to Support Research in Paediatric Oncology
Recordati The 2026 Award is focused on research in paediatric oncology, specifically sarcomas Paediatric sarcomas are among the leading causes of cancer-related death in children, yet there has been ...
Global Market Stocks Estimated To Be Trading At A Discount In October 2025
As global markets navigate through a period of cautious optimism, driven by mixed economic signals and hawkish commentary from central banks, investors are keenly assessing the landscape for opportuni...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
